Home/Pipeline/Investigator-Initiated Studies (IIS) Support

Investigator-Initiated Studies (IIS) Support

Various (Cardiology, Oncology)

Clinical ResearchActiveN/A

Key Facts

Indication
Various (Cardiology, Oncology)
Phase
Clinical Research
Status
Active
Company

About Terumo Medical

Terumo Medical Corporation (TMC) is a fully integrated, revenue-generating subsidiary of the publicly traded Terumo Corporation (TSE: 4543), operating as a key driver of the group's North American and global business. With a mission to contribute to society through healthcare, TMC has achieved a leading position across multiple medical device domains, including vascular intervention, drug delivery systems, and contract development services. Its strategy is built on a diversified, multi-platform approach that spans proprietary R&D, manufacturing, and direct sales, mitigating reliance on any single technology while addressing broad needs across the healthcare continuum from acute intervention to daily clinical care.

View full company profile